|
Drug-eluting stent - Wikipedia, the free encyclopedia
|
|
Read about the CYPHER® Stent for coronary heart disease. Learn about the safety and benefits of the stent procedure. ... The CYPHER® Stent also carries the risks associated with the drug sirolimus. Talk to your doctor ... Sirolimus-eluting Stent made by Cordis Corporation pursuant to a license from Wyeth Pharmaceuticals.
|
||
|
The following article provides an overview of drug-eluting stents (a.k.a "drug coated stents" or "medicated stents" or "DES") which gives a basic understanding of the history and mechanisms of these devices...
|
||
|
Drug-eluting stents: A Mayo Clinic doctor discusses their pros and cons. ... Drug-eluting stents and bare-metal stents are often used to treat clogged arteries. A Mayo Clinic doctor compares stents and discusses whether drug-eluting stents increase your heart attack risk.
|
||
|
Drug-eluting stent approved for clogged heart arteries ROCKVILLE, MD., April 24, 2003 -- The FDA has approved the first drug-eluting stent, called ... ROCKVILLE, MD., April 24, 2003 -- The FDA has approved the first drug-eluting stent, called "Cypher stent", for angioplasty procedures to open clogged coronary arteries.
|
||
|
Unlike drug-eluting stents, Genous, which is coated with an antibody, captures a patient's endothelial progenitor cells (EPCs) to accelerate the natural healing process. EPCs circulate in the bloodstream and are involved in the repair of blood vessels.
|
||
|
Original Article from The New England Journal of Medicine -- Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction ... Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarctio...
|
||
|
Concerns about the safety of drug-eluting stents have received much publicity, primarily related to a small increase in the number of blood clots that develop within drug-eluting stents late (more than 1 year) after implantation.
|
||
|
ACC 2006: Does the type of implanted stent (drug-eluting vs bare-metal) influence the incidence of late clinical events after discontinuing clopidogrel therapy related to stent thrombosis? ... BMS = bare-metal stent; CABG = coronary artery bypass graft; DES = drug-eluting stent; GP = glycoprotein; LAD = left anterior...
|
||
|
The objective of the study was to evaluate the medium-term clinical outcome and the potential for adverse effects when very long segments (ie, ≥64 mm of stented length) are treated by drug-eluting stent (DES) implantation, an approach colloquially referred to as a "full metal jacket.";
|